First Trust Advisors LP Genmab A/S Transaction History

First Trust Advisors LP

$101 Billion
Q3 2024

A detailed history of First Trust Advisors LP transactions in Genmab A/S stock. As of the latest transaction made, First Trust Advisors LP holds 1,393,047 shares of GMAB stock, worth $28.7 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,393,047

Previous 1,208,973 15.23%

Holding current value

$28.7 Million

Previous $30.4 Million 11.79%

% of portfolio

0.03%

Previous 0.03%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$23.84 - $28.48 $4.39 Million - $5.24 Million	184,074 Added 15.23%	1,393,047 $34 Million
Q2 2024 Aug 13, 2024	SELL	$25.13 - $30.27 $517,602 - $623,471	-20,597 Reduced 1.68%	1,208,973 $30.4 Million
Q1 2024 May 13, 2024	SELL	$26.43 - $32.77 $1.07 Million - $1.33 Million	-40,525 Reduced 3.19%	1,229,570 $36.8 Million
Q4 2023 Feb 13, 2024	BUY	$27.94 - $35.44 $4.9 Million - $6.21 Million	175,292 Added 16.01%	1,270,095 $40.4 Million
Q3 2023 Nov 13, 2023	SELL	$35.27 - $42.24 $3.5 Million - $4.19 Million	-99,303 Reduced 8.32%	1,094,803 $38.6 Million
Q2 2023 Aug 14, 2023	SELL	$37.4 - $42.94 $3.03 Million - $3.47 Million	-80,887 Reduced 6.34%	1,194,106 $45.4 Million
Q1 2023 May 15, 2023	BUY	$34.88 - $43.22 $2.78 Million - $3.45 Million	79,840 Added 6.68%	1,274,993 $48.1 Million
Q4 2022 Feb 09, 2023	SELL	$33.8 - $47.06 $3.26 Million - $4.53 Million	-96,347 Reduced 7.46%	1,195,153 $50.7 Million
Q3 2022 Nov 14, 2022	BUY	$31.52 - $373.61 $40.7 Million - $483 Million	1,291,500 New	1,291,500 $41.5 Million
Q2 2022 Aug 12, 2022	SELL	$26.83 - $38.57 $2.08 Million - $2.99 Million	-77,538 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$30.95 - $39.68 $2.07 Million - $2.66 Million	-66,941 Reduced 46.33%	77,538 $2.81 Million
Q4 2021 Feb 08, 2022	SELL	$35.87 - $47.12 $6.14 Million - $8.07 Million	-171,287 Reduced 54.24%	144,479 $5.72 Million
Q3 2021 Nov 15, 2021	SELL	$41.55 - $48.72 $6.84 Million - $8.03 Million	-164,722 Reduced 34.28%	315,766 $13.8 Million
Q2 2021 Aug 16, 2021	BUY	$32.88 - $44.57 $15.8 Million - $21.4 Million	480,488 New	480,488 $19.6 Million
Q1 2021 May 14, 2021	SELL	$30.92 - $44.4 $22.3 Million - $32 Million	-719,688 Closed	0 $0
Q4 2020 Feb 02, 2021	BUY	$33.66 - $40.76 $11.9 Million - $14.4 Million	353,483 Added 96.53%	719,688 $29.3 Million
Q3 2020 Nov 05, 2020	BUY	$33.07 - $38.68 $7.55 Million - $8.84 Million	228,434 Added 165.81%	366,205 $13.4 Million
Q2 2020 Jul 22, 2020	BUY	$20.05 - $33.89 $1.45 Million - $2.44 Million	72,131 Added 109.89%	137,771 $4.67 Million
Q1 2020 May 06, 2020	BUY	$17.15 - $25.22 $511,996 - $752,917	29,854 Added 83.42%	65,640 $1.39 Million
Q4 2019 Feb 03, 2020	BUY	$18.88 - $24.14 $675,639 - $863,874	35,786 New	35,786 $799,000

Others Institutions Holding GMAB

# of Institutions

236

Shares Held

52.5M

Call Options Held

10.2K

Put Options Held

25.5K

View Full List

About GENMAB A/S

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $13.6B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

More about GMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Account

First Trust Advisors LP Genmab A/S Transaction History